Central nervous system effects of 5-HT receptors: a potential target for neurodegenerative diseases.

Alejandro Quintero-Villegas, Sergio Iván Valdés-Ferrer

Journal: Molecular medicine (Cambridge, Mass.) 2022;28(1):70

PMID: 35725396

Abstract

5-HT receptors (5-HTR) are the most recently identified among the family of serotonin receptors. Their role in health and disease, particularly as mediators of, and druggable targets for, neurodegenerative diseases, is incompletely understood. Unlike other serotonin receptors, for which abundant preclinical and clinical data evaluating their effect on neurodegenerative conditions exist, the available information on the role of the 5-HTR receptor is limited. In this review, we describe the signaling pathways and cellular mechanisms implicated in the activation of the 5-HTR; also, we analyze different mechanisms of neurodegeneration and the potential therapeutic implications of pharmacological interventions for 5-HTR signaling.

© 2022. The Author(s).

Address: Department of Neurology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Department of Neurology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. [email protected].; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. [email protected].; Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, USA. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.